Literature DB >> 22162252

In vitro three-dimensional (3D) models in cancer research: an update.

Lauren C Kimlin1, Giovanna Casagrande, Victoria M Virador.   

Abstract

Tissues are three-dimensional (3D) entities as is the tumor that arises within them. Though disaggregated cancerous tissues have produced numerous cell lines for basic and applied research, it is generally agreed that these lines are poor models of in vivo phenomena. In this review we focus on in vitro 3D models used in cancer research, particularly their contribution to molecular studies of the early stages of metastasis, angiogenesis, the tumor microenvironment, and cancer stem cells. We present a summary of the various formats used in the field of tissue bioengineering as they apply to mechanistic modeling of cancer stages or processes. In addition we list studies that model specific types of malignancies, highlight drastic differences in results between 3D in vitro models and classical monolayer culturing techniques, and establish the need for standardization of 3D models for meaningful preclinical and therapeutic testing.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22162252     DOI: 10.1002/mc.21844

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  93 in total

Review 1.  Tissue-engineered models of human tumors for cancer research.

Authors:  Aranzazu Villasante; Gordana Vunjak-Novakovic
Journal:  Expert Opin Drug Discov       Date:  2015-02-07       Impact factor: 6.098

2.  Prostate cancer organoids: a potential new tool for testing drug sensitivity.

Authors:  Ian Vela; Yu Chen
Journal:  Expert Rev Anticancer Ther       Date:  2015-01-20       Impact factor: 4.512

Review 3.  Advances in multicellular spheroids formation.

Authors:  X Cui; Y Hartanto; H Zhang
Journal:  J R Soc Interface       Date:  2017-02       Impact factor: 4.118

4.  Tissue-Engineered Model of Human Osteolytic Bone Tumor.

Authors:  Aranzazu Villasante; Alessandro Marturano-Kruik; Samuel T Robinson; Zen Liu; X Edward Guo; Gordana Vunjak-Novakovic
Journal:  Tissue Eng Part C Methods       Date:  2017-02       Impact factor: 3.056

Review 5.  Phenotypic screening in cancer drug discovery - past, present and future.

Authors:  John G Moffat; Joachim Rudolph; David Bailey
Journal:  Nat Rev Drug Discov       Date:  2014-07-18       Impact factor: 84.694

6.  Screening candidate metastasis-associated genes in three-dimensional HCC spheroids with different metastasis potential.

Authors:  Rongxin Chen; Yinying Dong; Xiaoying Xie; Jie Chen; Dongmei Gao; Yinkun Liu; Zhenggang Ren; Jiefeng Cui
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

7.  Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas.

Authors:  Francesca Boscolo Sesillo; Alessandra Sacco
Journal:  J Vis Exp       Date:  2019-09-13       Impact factor: 1.355

8.  Beta-hairpin hydrogels as scaffolds for high-throughput drug discovery in three-dimensional cell culture.

Authors:  Peter Worthington; Katherine M Drake; Zhiqin Li; Andrew D Napper; Darrin J Pochan; Sigrid A Langhans
Journal:  Anal Biochem       Date:  2017-07-27       Impact factor: 3.365

9.  Three-Dimensional Culture Assay to Explore Cancer Cell Invasiveness and Satellite Tumor Formation.

Authors:  Marie-France Côté; Audrey Turcotte; Charles Doillon; Stephane Gobeil
Journal:  J Vis Exp       Date:  2016-08-18       Impact factor: 1.355

10.  Epigenetic reprogramming modulates malignant properties of human liver cancer.

Authors:  Chiara Raggi; Valentina M Factor; Daekwan Seo; Agnes Holczbauer; Matthew C Gillen; Jens U Marquardt; Jesper B Andersen; Marian Durkin; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2014-05-01       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.